Matches in Wikidata for { <http://www.wikidata.org/entity/Q80403147> ?p ?o ?g. }
Showing items 1 to 95 of
95
with 100 items per page.
- Q80403147 description "artículu científicu espublizáu en xineru de 2003" @default.
- Q80403147 description "im Jahr 2003 veröffentlichter wissenschaftlicher Artikel" @default.
- Q80403147 description "scientific article published on 01 January 2003" @default.
- Q80403147 description "wetenschappelijk artikel" @default.
- Q80403147 description "наукова стаття, опублікована в січні 2003" @default.
- Q80403147 name "Efficacy of UFT plus Tamoxifen for Estrogen-Receptor-Positive Breast Cancer and Tamoxifen plus UFT for Estrogen-Receptor-Negative Breast Cancer : Adjuvant Therapy after Administration of Mitomycin" @default.
- Q80403147 name "Efficacy of UFT plus Tamoxifen for Estrogen-Receptor-Positive Breast Cancer and Tamoxifen plus UFT for Estrogen-Receptor-Negative Breast Cancer : Adjuvant Therapy after Administration of Mitomycin" @default.
- Q80403147 name "Efficacy of UFT plus Tamoxifen for Estrogen-Receptor-Positive Breast Cancer and Tamoxifen plus UFT for Estrogen-Receptor-Negative Breast Cancer : Adjuvant Therapy after Administration of Mitomycin" @default.
- Q80403147 type Item @default.
- Q80403147 label "Efficacy of UFT plus Tamoxifen for Estrogen-Receptor-Positive Breast Cancer and Tamoxifen plus UFT for Estrogen-Receptor-Negative Breast Cancer : Adjuvant Therapy after Administration of Mitomycin" @default.
- Q80403147 label "Efficacy of UFT plus Tamoxifen for Estrogen-Receptor-Positive Breast Cancer and Tamoxifen plus UFT for Estrogen-Receptor-Negative Breast Cancer : Adjuvant Therapy after Administration of Mitomycin" @default.
- Q80403147 label "Efficacy of UFT plus Tamoxifen for Estrogen-Receptor-Positive Breast Cancer and Tamoxifen plus UFT for Estrogen-Receptor-Negative Breast Cancer : Adjuvant Therapy after Administration of Mitomycin" @default.
- Q80403147 prefLabel "Efficacy of UFT plus Tamoxifen for Estrogen-Receptor-Positive Breast Cancer and Tamoxifen plus UFT for Estrogen-Receptor-Negative Breast Cancer : Adjuvant Therapy after Administration of Mitomycin" @default.
- Q80403147 prefLabel "Efficacy of UFT plus Tamoxifen for Estrogen-Receptor-Positive Breast Cancer and Tamoxifen plus UFT for Estrogen-Receptor-Negative Breast Cancer : Adjuvant Therapy after Administration of Mitomycin" @default.
- Q80403147 prefLabel "Efficacy of UFT plus Tamoxifen for Estrogen-Receptor-Positive Breast Cancer and Tamoxifen plus UFT for Estrogen-Receptor-Negative Breast Cancer : Adjuvant Therapy after Administration of Mitomycin" @default.
- Q80403147 P1433 Q80403147-53E07F81-9D55-4DF4-AF17-A1C173B88DCE @default.
- Q80403147 P1476 Q80403147-7E259E20-E9BC-4DFB-BCC4-73368D6BD83E @default.
- Q80403147 P2093 Q80403147-1D3CBFDC-7500-4F3E-BFAE-A2A9C4EF1686 @default.
- Q80403147 P2093 Q80403147-344917F3-3C46-4F6E-A8E8-05F5944A3718 @default.
- Q80403147 P2093 Q80403147-3A0D17D2-8ACF-43A7-B7A4-2BC0F94BF3C7 @default.
- Q80403147 P2093 Q80403147-3B0FD2E5-F88A-4E89-BBD1-335839AE2211 @default.
- Q80403147 P2093 Q80403147-45C916B8-BDB7-4413-8EA9-B11A268E1E57 @default.
- Q80403147 P2093 Q80403147-84A96F83-1F60-4BE3-A1CA-613621BC10F6 @default.
- Q80403147 P2093 Q80403147-8A2B6700-B447-4C2C-B435-D902ADD5D0A2 @default.
- Q80403147 P2093 Q80403147-B3AD2634-E09A-4212-A5B1-D468C9E33783 @default.
- Q80403147 P2093 Q80403147-E9252FD8-7337-4F76-A248-1D062646037D @default.
- Q80403147 P2860 Q80403147-151F96CA-947C-4430-AF0B-27ECF1AAF9D0 @default.
- Q80403147 P2860 Q80403147-3D8C397C-C2A3-40DC-9411-E58BA15F83CE @default.
- Q80403147 P2860 Q80403147-3F4C8D2C-AF8D-45E5-8FAB-1EAD9F82C487 @default.
- Q80403147 P2860 Q80403147-41BC3D27-E8A1-4DF3-8CC4-F741E43AA399 @default.
- Q80403147 P2860 Q80403147-58046230-BECD-4D00-965C-FB646EC2BD47 @default.
- Q80403147 P2860 Q80403147-5A1FA63C-2C0B-4C5F-8470-1A5F676A8D99 @default.
- Q80403147 P2860 Q80403147-69221342-0A71-422B-A94F-30CEB13FCEE0 @default.
- Q80403147 P2860 Q80403147-6E0D6102-1B8E-4BB4-B160-699BBEF7A18D @default.
- Q80403147 P2860 Q80403147-78A5603C-F167-4E4C-A9EB-AB16C1ED107A @default.
- Q80403147 P2860 Q80403147-8321379A-34F9-49F8-8491-ABF528CF6FCD @default.
- Q80403147 P2860 Q80403147-83882E60-D2F1-47F1-A8E9-BC36B764DCFB @default.
- Q80403147 P2860 Q80403147-996078A2-B0B7-4297-BC96-10B16ED57348 @default.
- Q80403147 P2860 Q80403147-9E4D639F-0B9B-446C-A3B7-786977C52A96 @default.
- Q80403147 P2860 Q80403147-A2635098-DC77-44F0-9627-6D9E34E6C6FA @default.
- Q80403147 P2860 Q80403147-AADFD864-14BE-4E53-B2D8-49929C972C0A @default.
- Q80403147 P2860 Q80403147-AFA41B7B-69BF-4FD0-BAFE-DE3A0C7C2AB4 @default.
- Q80403147 P2860 Q80403147-B2A031BB-45C4-4CC8-9315-52AC93A04C15 @default.
- Q80403147 P2860 Q80403147-EAE15989-BDE3-46A5-BF87-90CAB5D97494 @default.
- Q80403147 P304 Q80403147-903E6C37-5F5C-4634-B280-ECCBDE1725AA @default.
- Q80403147 P31 Q80403147-15F72502-A646-44C0-A57F-997C721621D4 @default.
- Q80403147 P356 Q80403147-3B84277C-E4A7-4890-B307-3D27BE760DC4 @default.
- Q80403147 P433 Q80403147-55A45EA4-099B-457C-885E-2891422E0C9A @default.
- Q80403147 P478 Q80403147-F46D3C96-A9A2-48A3-8E69-004195D9E5D9 @default.
- Q80403147 P577 Q80403147-70FE8ECA-54CB-4909-BFC8-E64ADAA24719 @default.
- Q80403147 P698 Q80403147-6AB6A8E4-CBF6-434C-888E-96BA75B391BE @default.
- Q80403147 P921 Q80403147-01C86807-9CCC-4613-8905-20714FA4EA74 @default.
- Q80403147 P921 Q80403147-37484C02-78B0-4BF7-B6BD-67703B3665A8 @default.
- Q80403147 P921 Q80403147-B1A218F2-EC41-44EE-B462-2FDF58BA996E @default.
- Q80403147 P356 00044011-200323110-00001 @default.
- Q80403147 P698 17536882 @default.
- Q80403147 P1433 Q15753215 @default.
- Q80403147 P1476 "Efficacy of UFT plus Tamoxifen for Estrogen-Receptor-Positive Breast Cancer and Tamoxifen plus UFT for Estrogen-Receptor-Negative Breast Cancer : Adjuvant Therapy after Administration of Mitomycin" @default.
- Q80403147 P2093 "Adjuvant Chemoendocrine Therapy for Breast Cancer (ACETBC) Study Group, Hokkaido District" @default.
- Q80403147 P2093 "Atsunobu Hata" @default.
- Q80403147 P2093 "Junichi Uchino" @default.
- Q80403147 P2093 "Kazuaki Asaishi" @default.
- Q80403147 P2093 "Koichi Hirata" @default.
- Q80403147 P2093 "Masami Ogita" @default.
- Q80403147 P2093 "Michio Mito" @default.
- Q80403147 P2093 "Tatsuzo Tanabe" @default.
- Q80403147 P2093 "Yoshihiko Kubo" @default.
- Q80403147 P2860 Q29619251 @default.
- Q80403147 P2860 Q33491971 @default.
- Q80403147 P2860 Q35978157 @default.
- Q80403147 P2860 Q41580781 @default.
- Q80403147 P2860 Q43508347 @default.
- Q80403147 P2860 Q43535933 @default.
- Q80403147 P2860 Q53350484 @default.
- Q80403147 P2860 Q67854780 @default.
- Q80403147 P2860 Q68514576 @default.
- Q80403147 P2860 Q68925779 @default.
- Q80403147 P2860 Q69855875 @default.
- Q80403147 P2860 Q70195198 @default.
- Q80403147 P2860 Q70211555 @default.
- Q80403147 P2860 Q70753098 @default.
- Q80403147 P2860 Q72057610 @default.
- Q80403147 P2860 Q73207811 @default.
- Q80403147 P2860 Q73223970 @default.
- Q80403147 P2860 Q73224174 @default.
- Q80403147 P304 "689-699" @default.
- Q80403147 P31 Q13442814 @default.
- Q80403147 P356 "10.2165/00044011-200323110-00001" @default.
- Q80403147 P433 "11" @default.
- Q80403147 P478 "23" @default.
- Q80403147 P577 "2003-01-01T00:00:00Z" @default.
- Q80403147 P698 "17536882" @default.
- Q80403147 P921 Q18553636 @default.
- Q80403147 P921 Q18553637 @default.
- Q80403147 P921 Q412178 @default.